Literature DB >> 11165771

Identification of protein kinase C isoforms involved in interferon-gamma-induced expression of inducible nitric oxide synthase in murine BV2 microglia.

J Kang1, M Yang, I Jou, E Joe.   

Abstract

Microglia are major inflammatory cells of the brain. It has been known that interferon-gamma (IFN-gamma) induces nitric oxide (NO)/inducible nitric oxide synthase (iNOS) in microglia, and that protein kinase C (PKC) mediates the action of IFN-gamma. In this study, we investigated isoforms of PKC that are involved in IFN-gamma-induced activation of microglia using BV2 murine microglial cells. NO release/iNOS expression in IFN-gamma -treated BV2 cells was reduced in the presence of PKC inhibitors (Gö 6976 and BIM), and by long-term pre-treatment (48 h) of cells with phorbol-12-myristate-13-acetate (PMA) or thymeleatoxin. PMA depleted alpha, beta, delta, and epsilon isoforms, and thymeleatoxin depleted alpha, beta, and epsilon isoforms although gamma, eta, iota, lambda, theta, mu, and zeta were also detected in these cells. Furthermore, IFN-gamma phosphorylated alpha and epsilon on their tyrosine residues. These results suggested that alpha and epsilon could be the major PKC isoforms involved in signaling pathways of IFN-gamma to induce NO/iNOS expression in BV2 microglia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165771     DOI: 10.1016/s0304-3940(01)01515-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin.

Authors:  Richard Milner; Iain L Campbell
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

2.  Inhibition of classical PKC isoenzymes downregulates STAT1 activation and iNOS expression in LPS-treated murine J774 macrophages.

Authors:  Tiina Salonen; Outi Sareila; Ulla Jalonen; Hannu Kankaanranta; Raimo Tuominen; Eeva Moilanen
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

3.  Inhibition of the PKCγ-ε pathway relieves from meningeal nociception in an animal model: an innovative perspective for migraine therapy?

Authors:  Nicoletta Galeotti; Carla Ghelardini
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

4.  Conventional-type protein kinase C contributes to phorbol ester-induced inhibition of rat myometrial tension.

Authors:  Bokyung Kim; Yoon-Sun Kim; Jiyun Ahn; Junghwan Kim; SungIl Cho; Kyung-Jong Won; Hiroshi Ozaki; Hideaki Karaki; Sang-Mok Lee
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

5.  Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation.

Authors:  Kyoung-Jin Min; Myung-soon Yang; Seung-Up Kim; Ilo Jou; Eun-hye Joe
Journal:  J Neurosci       Date:  2006-02-08       Impact factor: 6.167

6.  Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cells.

Authors:  Jie Wen; Rachel Ribeiro; Yumin Zhang
Journal:  J Neuroinflammation       Date:  2011-04-21       Impact factor: 8.322

7.  Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia.

Authors:  Beomsue Kim; Myung-Soon Yang; Dongjoo Choi; Jong-Hyeon Kim; Hye-Sun Kim; Wongi Seol; Sangdun Choi; Ilo Jou; Eun-Young Kim; Eun-Hye Joe
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

8.  Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling.

Authors:  Alexandra S Baer; Yasir A Syed; Sung Ung Kang; Dieter Mitteregger; Raluca Vig; Charles Ffrench-Constant; Robin J M Franklin; Friedrich Altmann; Gert Lubec; Mark R Kotter
Journal:  Brain       Date:  2009-02       Impact factor: 13.501

9.  Suppression of miR-155 Expression in IFN-γ-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression.

Authors:  Jong-Hyeon Kim; Ilo Jou; Eun-Hye Joe
Journal:  Exp Neurobiol       Date:  2014-06-13       Impact factor: 3.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.